- Home
- HALO vs AXS Comparison
HALO vs AXS Comparison
Compare HALO & AXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- AXS
- Stock Information
- Founded
- HALO 1998
- AXS 2001
- Country
- HALO United States
- AXS Bermuda
- Employees
- HALO N/A
- AXS N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- AXS Property-Casualty Insurers
- Sector
- HALO Health Care
- AXS Finance
- Exchange
- HALO Nasdaq
- AXS Nasdaq
- Market Cap
- HALO 7.4B
- AXS 8.1B
- IPO Year
- HALO N/A
- AXS N/A
- Fundamental
- Price
- HALO $54.54
- AXS $100.66
- Analyst Decision
- HALO Buy
- AXS Strong Buy
- Analyst Count
- HALO 9
- AXS 9
- Target Price
- HALO $63.56
- AXS $107.75
- AVG Volume (30 Days)
- HALO 3.3M
- AXS 547.9K
- Earning Date
- HALO 05-06-2025
- AXS 04-30-2025
- Dividend Yield
- HALO N/A
- AXS 1.75%
- EPS Growth
- HALO 55.40
- AXS 54.31
- EPS
- HALO 3.76
- AXS 10.08
- Revenue
- HALO $1,084,306,000.00
- AXS $6,055,200,000.00
- Revenue This Year
- HALO $25.77
- AXS $4.15
- Revenue Next Year
- HALO $18.01
- AXS $8.03
- P/E Ratio
- HALO $14.51
- AXS $10.00
- Revenue Growth
- HALO 25.64
- AXS 5.79
- 52 Week Low
- HALO $42.01
- AXS $68.02
- 52 Week High
- HALO $70.51
- AXS $103.85
- Technical
- Relative Strength Index (RSI)
- HALO 44.48
- AXS 55.47
- Support Level
- HALO $52.43
- AXS $98.97
- Resistance Level
- HALO $54.26
- AXS $103.85
- Average True Range (ATR)
- HALO 3.42
- AXS 1.81
- MACD
- HALO -0.49
- AXS -0.12
- Stochastic Oscillator
- HALO 30.60
- AXS 41.47
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.